Correlation of amyloid-β and hyperphosphorylated tau protein in phosphorylated CRMP2 accumulation in Alzheimer's disease

被引：0
|
作者：
Kitamura, Yoshihisa [1 ]
Takata, Kazuyuki [1 ]
Shimohama, Shun [2 ]
Taniguchi, Takashi [1 ]
机构：
[1] Kyoto Pharm Univ, Dept Neurobiol, Yamashina Ku, Kyoto 6078414, Japan
[2] Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2010年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：134P / 134P
页数：1
相关论文
共 50 条
  • [1] Pathogenesis of Alzheimer's Disease: Role of Amyloid-β and Hyperphosphorylated Tau Protein
    Sajjad, Rabia
    Arif, Rawaba
    Shah, A. A.
    Manzoor, I.
    Mustafa, G.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (04) : 581 - 591
  • [2] Accumulated Amyloid-β Peptide and Hyperphosphorylated Tau Protein: Relationship and Links in Alzheimer's Disease
    Huang, Han-Chang
    Jiang, Zhao-Feng
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (01) : 15 - 27
  • [3] Pyroglutamylated amyloid-β correlates with hyperphosphorylated tau and severity of Alzheimer's disease
    Walker, L.
    Mandler, M.
    Santic, R.
    Hanson, P.
    Upadhaya, A. R.
    Colloby, S. J.
    Morris, C. M.
    Thal, D. R.
    Thomas, A. J.
    Schneeberger, A.
    Attems, J.
    BRAIN PATHOLOGY, 2014, 24 : 42 - 42
  • [4] Pyroglutamylated Amyloid-β correlates with Hyperphosphorylated Tau and Severity of Alzheimer's Disease
    Attems, Johannes
    Walker, Lauren
    Santic, Radmila
    Upadhaya, Ajeet Rijal
    Colloby, Sean
    Thal, Dietmar
    Thomas, Alan
    Schneeberger, Achim
    Mandler, Markus
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (06): : 587 - 587
  • [5] Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease
    Mandler, Markus
    Walker, Lauren
    Santic, Radmila
    Hanson, Peter
    Upadhaya, Ajeet Rijal
    Colloby, Sean J.
    Morris, Christopher M.
    Thal, Dietmar R.
    Thomas, Alan J.
    Schneeberger, Achim
    Attems, Johannes
    ACTA NEUROPATHOLOGICA, 2014, 128 (01) : 67 - 79
  • [6] Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease
    Markus Mandler
    Lauren Walker
    Radmila Santic
    Peter Hanson
    Ajeet Rijal Upadhaya
    Sean J. Colloby
    Christopher M. Morris
    Dietmar R. Thal
    Alan J. Thomas
    Achim Schneeberger
    Johannes Attems
    Acta Neuropathologica, 2014, 128 : 67 - 79
  • [7] Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease
    Pradeepkiran, Jangampalli Adi
    Baig, Javaria
    Islam, Md Ariful
    Kshirsagar, Sudhir
    Reddy, Hemachandra
    AGING AND DISEASE, 2025,
  • [8] Amyloid-β and Hyperphosphorylated tau Synergy Drives Metabolic Decline in Preclinical Alzheimer's Disease
    Pascoal, Tharick
    Mathotaarachchi, Sulantha
    Benedet, Andrea
    Beaudry, Tom
    Gauther, Serge
    Neto, Pedro Rosa
    NEUROLOGY, 2016, 86
  • [9] Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease
    T A Pascoal
    S Mathotaarachchi
    S Mohades
    A L Benedet
    C-O Chung
    M Shin
    S Wang
    T Beaudry
    M S Kang
    J-P Soucy
    A Labbe
    S Gauthier
    P Rosa-Neto
    Molecular Psychiatry, 2017, 22 : 306 - 311
  • [10] Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease
    Pascoal, T. A.
    Mathotaarachchi, S.
    Mohades, S.
    Benedet, A. L.
    Chung, C-O
    Shin, M.
    Wang, S.
    Beaudry, T.
    Kang, M. S.
    Soucy, J-P
    Labbe, A.
    Gauthier, S.
    Rosa-Neto, P.
    MOLECULAR PSYCHIATRY, 2017, 22 (02) : 306 - 311
12345